BioCentury
ARTICLE | Company News

T-Cell Factory, Kite Pharma deal

April 20, 2015 7:00 AM UTC

Cancer company Kite acquired T-Cell Factory for EUR20 million ($21.1 million) in cash and stock and up to EUR242.5 million ($256.2 million) in clinical, regulatory and sales milestones. The deal inclu...